Literature DB >> 8668668

Estimation of the increase in solubility of drugs as a function of bile salt concentration.

S D Mithani1, V Bakatselou, C N TenHoor, J B Dressman.   

Abstract

PURPOSE: The objective of this study was to develop a model to predict the extent to which bile salts can enhance the solubility of a drug, based on the physicochemical properties of the compound. The ability to predict bile salt solubilization of poorly soluble drugs would be a key component in determining which drugs will exhibit fed vs. fasted differences in drug absorption.
METHODS: A correlation between the logarithm of the octanol/water partition coefficient [log P] of six steroidal compounds and their solubilities in the presence of various concentrations of sodium taurocholate at 37 degrees C, log [SR] = 2.234 + 0.606 log [P] (r2 = 0.987) where SR is the ratio of the stabilization capacity of the bile salt to the solubilization capacity of water for the drug, was used to predict the solubility of the compounds in presence of sodium taurocholate were then measured.
RESULTS: The predicted solubilities were within 10% of the experimentally observed solubilities for griseofulvin, cyclosporin A and pentazocine. The model overpredicted the solubility of phenytoin and diazepam in 15 mM sodium taurocholate solution by a factor of 1.33 and 1.62 respectively.
CONCLUSIONS: The expected increase in solubility as a function of bile salt concentration can be estimated on the basis of the partition coefficient and aqueous solubility of the compound.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8668668     DOI: 10.1023/a:1016062224568

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  22 in total

1.  Solubility and ionization characteristics of phenytoin.

Authors:  P A Schwartz; C T Rhodes; J W Cooper
Journal:  J Pharm Sci       Date:  1977-07       Impact factor: 3.534

2.  Human pharmacology of griseofulvin: the effect of fat intake on gastrointestinal absorption.

Authors:  R G CROUNSE
Journal:  J Invest Dermatol       Date:  1961-12       Impact factor: 8.551

3.  Interaction of substituted benzoic acids with polysorbate 20 micelles.

Authors:  J H Collett; L Koo
Journal:  J Pharm Sci       Date:  1975-07       Impact factor: 3.534

4.  Solubilization of hydrocortisone, dexamethasone, testosterone and progesterone by long-chain polyoxyethylene surfactants.

Authors:  B W Barry; D I El Eini
Journal:  J Pharm Pharmacol       Date:  1976-03       Impact factor: 3.765

5.  Micellar solubilization of barbiturates. I. Solubilities of certain barbiturates in polysorbates of varying hydrophobic chain length.

Authors:  A A Ismail; M W Gouda; M M Motawi
Journal:  J Pharm Sci       Date:  1970-02       Impact factor: 3.534

6.  Upper gastrointestinal (GI) pH in young, healthy men and women.

Authors:  J B Dressman; R R Berardi; L C Dermentzoglou; T L Russell; S P Schmaltz; J L Barnett; K M Jarvenpaa
Journal:  Pharm Res       Date:  1990-07       Impact factor: 4.200

7.  Effect of food and a monoglyceride emulsion formulation on danazol bioavailability.

Authors:  W N Charman; M C Rogge; A W Boddy; B M Berger
Journal:  J Clin Pharmacol       Date:  1993-04       Impact factor: 3.126

8.  Influence of bile on the gastrointestinal absorption of phenytoin in rats.

Authors:  D Shinkuma; T Hamaguchi; Y Yamanaka; N Mizuno; N Yata
Journal:  Chem Pharm Bull (Tokyo)       Date:  1985-11       Impact factor: 1.645

9.  Bile acid output and the interdigestive migrating motor complex in normals and in cholecystectomy patients.

Authors:  T L Peeters; G Vantrappen; J Janssens
Journal:  Gastroenterology       Date:  1980-10       Impact factor: 22.682

10.  Solubilization and wetting effects of bile salts on the dissolution of steroids.

Authors:  V Bakatselou; R C Oppenheim; J B Dressman
Journal:  Pharm Res       Date:  1991-12       Impact factor: 4.200

View more
  66 in total

1.  Dissolution of hydrocortisone in human and simulated intestinal fluids.

Authors:  B L Pedersen; H Brøndsted; H Lennernäs; F N Christensen; A Müllertz; H G Kristensen
Journal:  Pharm Res       Date:  2000-02       Impact factor: 4.200

2.  Exploring Canine-Human Differences in Product Performance. Part II: Use of Modeling and Simulation to Explore the Impact of Formulation on Ciprofloxacin In Vivo Absorption and Dissolution in Dogs.

Authors:  M N Martinez; B Mistry; V Lukacova; K A Lentz; J E Polli; S W Hoag; T Dowling; R Kona; R M Fahmy
Journal:  AAPS J       Date:  2017-03-06       Impact factor: 4.009

3.  Graphene oxide as an enzyme inhibitor: modulation of activity of α-chymotrypsin.

Authors:  Mrinmoy De; Stanley S Chou; Vinayak P Dravid
Journal:  J Am Chem Soc       Date:  2011-10-13       Impact factor: 15.419

4.  Noncovalent modification of chymotrypsin surface using an amphiphilic polymer scaffold: implications in modulating protein function.

Authors:  Britto S Sandanaraj; Dharma Rao Vutukuri; Joseph M Simard; Akamol Klaikherd; Rui Hong; Vincent M Rotello; S Thayumanavan
Journal:  J Am Chem Soc       Date:  2005-08-03       Impact factor: 15.419

5.  A novel strategy for physiologically based predictions of human pharmacokinetics.

Authors:  Hannah M Jones; Neil Parrott; Karin Jorga; Thierry Lavé
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

6.  Miniaturized rotating disk intrinsic dissolution rate measurement: effects of buffer capacity in comparisons to traditional wood's apparatus.

Authors:  Alex Avdeef; Oksana Tsinman
Journal:  Pharm Res       Date:  2008-07-22       Impact factor: 4.200

7.  Postprandial changes in solubilizing capacity of human intestinal fluids for BCS class II drugs.

Authors:  Sarah Clarysse; Dimitrios Psachoulias; Joachim Brouwers; Jan Tack; Pieter Annaert; Guus Duchateau; Christos Reppas; Patrick Augustijns
Journal:  Pharm Res       Date:  2009-03-07       Impact factor: 4.200

8.  Design and evaluation of a PEGylated lipopeptide equipped with drug-interactive motifs as an improved drug carrier.

Authors:  Peng Zhang; Jianqin Lu; Yixian Huang; Wenchen Zhao; Yifei Zhang; Xiaolan Zhang; Jiang Li; Raman Venkataramanan; Xiang Gao; Song Li
Journal:  AAPS J       Date:  2013-11-27       Impact factor: 4.009

9.  Application of physiologically based absorption modeling to formulation development of a low solubility, low permeability weak base: mechanistic investigation of food effect.

Authors:  Hefei Zhang; Binfeng Xia; Jennifer Sheng; Tycho Heimbach; Tsu-Han Lin; Handan He; Yanfeng Wang; Steven Novick; Ann Comfort
Journal:  AAPS PharmSciTech       Date:  2014-01-17       Impact factor: 3.246

10.  Effect of pancreatico-biliary secretions and GI transit time on the absorption and pharmacokinetic profile of ranitidine in humans.

Authors:  K S Reynolds; M H Song; W D Heizer; C B Burns; D A Sica; K L Brouwer
Journal:  Pharm Res       Date:  1998-08       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.